메뉴 건너뛰기




Volumn , Issue , 2010, Pages 515-530

Polycystic ovary syndrome

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84888128191     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-09841-8_33     Document Type: Chapter
Times cited : (6)

References (110)
  • 1
    • 0031773509 scopus 로고    scopus 로고
    • Prevalence of the polycystic ovarian syndrome in unselected black and white women of the Southeastern United States: A prospective study
    • Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovarian syndrome in unselected black and white women of the Southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078-3082.
    • (1998) J Clin Endocrinol Metab. , vol.83 , pp. 3078-3082
    • Knochenhauer, E.S.1    Key, T.J.2    Kahsar-Miller, M.3    Waggoner, W.4    Boots, L.R.5    Azziz, R.6
  • 2
    • 0001217801 scopus 로고
    • Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach
    • Dunaif A ed Boston: Blackwell Scientific
    • Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A ed. Polycystic Ovary Syndrome. Boston: Blackwell Scientific; 1995:337-384.
    • (1995) Polycystic Ovary Syndrome , pp. 337-384
    • Zawadzki, J.K.1    Dunaif, A.2
  • 3
    • 0346725827 scopus 로고    scopus 로고
    • Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary disease
    • Rotterdam ESHRE/ASRM - Sponsored PCOS Concensus Workshop Group
    • Rotterdam ESHRE/ASRM - Sponsored PCOS Concensus Workshop Group, "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary disease," Fertil Steril, vol 81, 19-25, 2004
    • (2004) Fertil Steril , vol.81 , pp. 19-25
  • 4
    • 0346186090 scopus 로고    scopus 로고
    • Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary disease
    • Rotterdam ESHRE/ASRM - Sponsored PCOS Concensus Workshop Group
    • Rotterdam ESHRE/ASRM - Sponsored PCOS Concensus Workshop Group, "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary disease," Human reproduction, vol 19, 41-47, 2004
    • (2004) Human Reproduction , vol.19 , pp. 41-47
  • 5
    • 0028899597 scopus 로고
    • Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus
    • Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med. 1995;98([Suppl]):33S-39S.
    • (1995) Am J Med. , vol.98 , Issue.SUPPL.
    • Dunaif, A.1
  • 6
    • 0038307320 scopus 로고    scopus 로고
    • Polycystic ovary syndrome and cardiovascular disease: Premature association?
    • Legro RS. Polycystic ovary syndrome and cardiovascular disease: premature association? Endocr Rev. 2003;24:302-312.
    • (2003) Endocr Rev. , vol.24 , pp. 302-312
    • Legro, R.S.1
  • 7
    • 0038440516 scopus 로고    scopus 로고
    • Polycystic ovary syndrome and endometrial carcinoma
    • Hardiman P, Pillay OS, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet. 2003;361:1810-1812.
    • (2003) Lancet. , vol.361 , pp. 1810-1812
    • Hardiman, P.1    Pillay, O.S.2    Atiomo, W.3
  • 9
    • 0001698606 scopus 로고
    • Amenorrhea associated with bilateral polycystic ovaries
    • Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181-186.
    • (1935) Am J Obstet Gynecol. , vol.29 , pp. 181-186
    • Stein, I.F.1    Leventhal, M.L.2
  • 10
    • 84980112064 scopus 로고
    • Virilism and thecal cell hyperplasia of the ovary syndrome
    • Culiner A, Shippel S. Virilism and thecal cell hyperplasia of the ovary syndrome. J Obstet Gynaecol Br Comm. 1949;56: 439-445.
    • (1949) J Obstet Gynaecol Br Comm. , vol.56 , pp. 439-445
    • Culiner, A.1    Shippel, S.2
  • 11
    • 70449220426 scopus 로고
    • The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system
    • McArthur JW, Ingersoll FW, Worcester J. The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system. J Clin Endocrinol Metab. 1958;18:1202-1215.
    • (1958) J Clin Endocrinol Metab. , vol.18 , pp. 1202-1215
    • McArthur, J.W.1    Ingersoll, F.W.2    Worcester, J.3
  • 12
    • 0016670977 scopus 로고
    • Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease
    • De Vane GW, Czekala NM, Judd HL, Yen SS. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol. 1975;121:496-500.
    • (1975) Am J Obstet Gynecol. , vol.121 , pp. 496-500
    • De Vane, G.W.1    Czekala, N.M.2    Judd, H.L.3    Yen, S.S.4
  • 14
    • 42749101427 scopus 로고    scopus 로고
    • The genetic basis of the polycystic ovary syndrome: A literature review including discussion of PPAR-g
    • Unluturk U, Harmanci A, Kocaefe C, Yildiz B. The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-g. PPAR Res. 2007:49109.
    • (2007) PPAR Res. , pp. 49109
    • Unluturk, U.1    Harmanci, A.2    Kocaefe, C.3    Yildiz, B.4
  • 15
    • 0033304934 scopus 로고    scopus 로고
    • The insulin-related ovarian regulatory system in health and disease
    • Poretsky L, Cataldo N, Rosenwaks Z, Giudice L. The insulin-related ovarian regulatory system in health and disease. Endocr Rev. 1999;20:535-582.
    • (1999) Endocr Rev. , vol.20 , pp. 535-582
    • Poretsky, L.1    Cataldo, N.2    Rosenwaks, Z.3    Giudice, L.4
  • 16
    • 0021027336 scopus 로고
    • A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome
    • Zumoff B, Freeman R, Coupey S, Saenger P, Markowitz M, Kream J. A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome. N Engl J Med. 1983;309:1206-1209.
    • (1983) N Engl J Med. , vol.309 , pp. 1206-1209
    • Zumoff, B.1    Freeman, R.2    Coupey, S.3    Saenger, P.4    Markowitz, M.5    Kream, J.6
  • 17
    • 10544240613 scopus 로고
    • The ovary
    • Felig P, Baxter JD, Broadus AE, Frohman LA, eds 2nd ed. New York: McGraw-Hill Book Company
    • McLachlan RI, Healy DL, Burger HG. The ovary. In: Felig P, Baxter JD, Broadus AE, Frohman LA, eds. Endocrinology and Metabolism. 2nd ed. New York: McGraw-Hill Book Company; 1987:951-983.
    • (1987) Endocrinology and Metabolism , pp. 951-983
    • McLachlan, R.I.1    Healy, D.L.2    Burger, H.G.3
  • 18
    • 0023277586 scopus 로고
    • Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency
    • Pang S, Softness B, Sweeney WJ, New MI. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency. N Engl J Med. 1987;316:1295-1301.
    • (1987) N Engl J Med. , vol.316 , pp. 1295-1301
    • Pang, S.1    Softness, B.2    Sweeney, W.J.3    New, M.I.4
  • 19
    • 0035217099 scopus 로고    scopus 로고
    • The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome
    • Nelson VL, Qin K-N, Rosenfeld RL, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86:5925-5933.
    • (2001) J Clin Endocrinol Metab. , vol.86 , pp. 5925-5933
    • Nelson, V.L.1    Qin, K.-N.2    Rosenfeld, R.L.3
  • 20
    • 0023336845 scopus 로고
    • The gonadotropic function of insulin
    • Poretsky L, Kalin M. The gonadotropic function of insulin. Endocr Rev. 1987;8:132-141.
    • (1987) Endocr Rev. , vol.8 , pp. 132-141
    • Poretsky, L.1    Kalin, M.2
  • 21
    • 0002551982 scopus 로고
    • Le virilisme pilaire et son association a l'insuffisance glycolytique (diabete des femmes a barbe
    • Archard C, Thiers J. Le virilisme pilaire et son association a l'insuffisance glycolytique (diabete des femmes a barbe. Bull Acad Nat Med. 1921;86:51.
    • (1921) Bull Acad Nat Med. , vol.86 , pp. 51
    • Archard, C.1    Thiers, J.2
  • 22
    • 0017154704 scopus 로고
    • The syndromes of insulin resistance and acanthosis nigricans: Insulin-receptor disorders in man
    • Kahn CR, Flier JS, Bar RS, et al. The syndromes of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man. N Engl J Med. 1976;294:739-745.
    • (1976) N Engl J Med. , vol.294 , pp. 739-745
    • Kahn, C.R.1    Flier, J.S.2    Bar, R.S.3
  • 23
    • 0016750268 scopus 로고
    • Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance
    • Flier JS, Kahn CR, Roth J, Bar RS. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science. 1975;190:63-65.
    • (1975) Science. , vol.190 , pp. 63-65
    • Flier, J.S.1    Kahn, C.R.2    Roth, J.3    Bar, R.S.4
  • 24
    • 0002245407 scopus 로고
    • Mutations of the insulin receptor gene
    • Moller DE ed New York: John Wiley & Sons
    • Taylor SI, Moller DE. Mutations of the insulin receptor gene. In: Moller DE ed. Insulin Resistance. New York: John Wiley & Sons; 1993:83-121.
    • (1993) Insulin Resistance , pp. 83-121
    • Taylor, S.I.1    Moller, D.E.2
  • 25
    • 0031456016 scopus 로고    scopus 로고
    • Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
    • Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774-800.
    • (1997) Endocr Rev. , vol.18 , pp. 774-800
    • Dunaif, A.1
  • 26
    • 2542490223 scopus 로고    scopus 로고
    • Pathogenesis of polycystic ovary syndrome: What is the role of obesity?
    • Salehi M, Bravo-Vera R, Sheikh A, Gouller A, Poretsky L. Pathogenesis of polycystic ovary syndrome: what is the role of obesity? Metabolism. 2004;53:358-376.
    • (2004) Metabolism. , vol.53 , pp. 358-376
    • Salehi, M.1    Bravo-Vera, R.2    Sheikh, A.3    Gouller, A.4    Poretsky, L.5
  • 27
    • 0029119085 scopus 로고
    • Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: A potential mechanism for insulin resistance in the polycystic ovary syndrome
    • Dunaif A, Book CB, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest. 1995;96: 801-810.
    • (1995) J Clin Invest. , vol.96 , pp. 801-810
    • Dunaif, A.1    Book, C.B.2    Schenker, E.3    Tang, Z.4
  • 28
    • 0025296906 scopus 로고
    • Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes
    • Svedberg J, Bjorntorp P, Smith U, et al. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes. 1990;39:570-574.
    • (1990) Diabetes. , vol.39 , pp. 570-574
    • Svedberg, J.1    Bjorntorp, P.2    Smith, U.3
  • 29
    • 0031014830 scopus 로고    scopus 로고
    • Role of fatty acids in the pathogenesis of insulin resistance and NIIDM
    • Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIIDM. Diabetes. 1997;46:3-10.
    • (1997) Diabetes. , vol.46 , pp. 3-10
    • Boden, G.1
  • 30
    • 0036296672 scopus 로고    scopus 로고
    • Skeletal muscle triglycerides: An aspect of regional adiposity and insulin resistance
    • Kelley DE. Skeletal muscle triglycerides: an aspect of regional adiposity and insulin resistance. Ann N Y Acad Sci. 2002;967:135-145.
    • (2002) Ann N y Acad Sci. , vol.967 , pp. 135-145
    • Kelley, D.E.1
  • 31
    • 0030061922 scopus 로고    scopus 로고
    • IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance
    • Hotamisligil GS, Peraldi P, Budavari A. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science. 1996;271:665-668.
    • (1996) Science. , vol.271 , pp. 665-668
    • Hotamisligil, G.S.1    Peraldi, P.2    Budavari, A.3
  • 32
    • 0344096623 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha in various tissues and of insulin-resistant obese Koletsky rats: Relations to insulin receptor characteristics
    • Hrebicek A, Rypka M, Chmela Z, et al. Tumor necrosis factor alpha in various tissues and of insulin-resistant obese Koletsky rats: relations to insulin receptor characteristics. Physiol Res. 1999;48:83-86.
    • (1999) Physiol Res. , vol.48 , pp. 83-86
    • Hrebicek, A.1    Rypka, M.2    Chmela, Z.3
  • 33
    • 0028141408 scopus 로고
    • Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: Relation to anthropometric, endocrine and metabolic variables
    • Holte J, Bergh T, Berne C, et al. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol. 1994;41:463-471.
    • (1994) Clin Endocrinol. , vol.41 , pp. 463-471
    • Holte, J.1    Bergh, T.2    Berne, C.3
  • 34
    • 0036063941 scopus 로고    scopus 로고
    • A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance
    • Ek I, Arner P, Ryden M, et al. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes. 2002;51:484-492.
    • (2002) Diabetes. , vol.51 , pp. 484-492
    • Ek, I.1    Arner, P.2    Ryden, M.3
  • 35
    • 0034892297 scopus 로고    scopus 로고
    • TNF-alpha hyperandrogenism: A clinical, biochemical, and molecular genetic study
    • Escobar-Morreale HF, Calvo RM, Sancho J, et al. TNF-alpha hyperandrogenism: A clinical, biochemical, and molecular genetic study. J Clin Endocrinol Metab. 2001;86:3761-3767.
    • (2001) J Clin Endocrinol Metab. , vol.86 , pp. 3761-3767
    • Escobar-Morreale, H.F.1    Calvo, R.M.2    Sancho, J.3
  • 37
    • 0022406388 scopus 로고
    • Distribution and characterization of the insulin and IGF-I receptors in the normal human ovary
    • Poretsky L, Grigorescu F, Seibel M, Moses AC, Flier JS. Distribution and characterization of the insulin and IGF-I receptors in the normal human ovary. J Clin Endocrinol Metab. 1985;61:728-734.
    • (1985) J Clin Endocrinol Metab. , vol.61 , pp. 728-734
    • Poretsky, L.1    Grigorescu, F.2    Seibel, M.3    Moses, A.C.4    Flier, J.S.5
  • 38
    • 0028279242 scopus 로고
    • Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins 1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries
    • El-Roeiy A, Chen X, Roberts VJ, et al. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins 1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab. 1994;78:1488-1496.
    • (1994) J Clin Endocrinol Metab. , vol.78 , pp. 1488-1496
    • El-Roeiy, A.1    Chen, X.2    Roberts, V.J.3
  • 39
    • 0020592186 scopus 로고
    • Effects of insulin on steroidogenesis in cultured porcine ovarian theca
    • Barbieri RL, Makris A, Ryan KJ. Effects of insulin on steroidogenesis in cultured porcine ovarian theca. Fertil Steril. 1983;40:237-241.
    • (1983) Fertil Steril. , vol.40 , pp. 237-241
    • Barbieri, R.L.1    Makris, A.2    Ryan, K.J.3
  • 40
    • 0026638365 scopus 로고
    • Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats
    • Poretsky L, Clemons J, Bogovich K. Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats. Metabolism. 1992;41:903-910.
    • (1992) Metabolism. , vol.41 , pp. 903-910
    • Poretsky, L.1    Clemons, J.2    Bogovich, K.3
  • 41
    • 0030020879 scopus 로고    scopus 로고
    • Insulin receptor mediates inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-1, on binding protein 1 (IGFBP-1) production in human granulosa cells
    • Poretsky L, Chandrasekher YA, Bai C, Liu HC, Rosenwaks Z, Giudice L. Insulin receptor mediates inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-1, on binding protein 1 (IGFBP-1) production in human granulosa cells. J Clin Endocrinol Metab. 1996;81:493-496.
    • (1996) J Clin Endocrinol Metab. , vol.81 , pp. 493-496
    • Poretsky, L.1    Chandrasekher, Y.A.2    Bai, C.3    Liu, H.C.4    Rosenwaks, Z.5    Giudice, L.6
  • 42
    • 0026061628 scopus 로고
    • On the paradox of insulin-induced hyperandrogenism in insulin-resistant states
    • Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev. 1991;12:3-13.
    • (1991) Endocr Rev. , vol.12 , pp. 3-13
    • Poretsky, L.1
  • 43
    • 0001721927 scopus 로고
    • The growth, development and prognosis of diabetic children
    • Joslin EP, Root HF, White P. The growth, development and prognosis of diabetic children. J Am Med Assoc. 1925;85:420-422.
    • (1925) J Am Med Assoc. , vol.85 , pp. 420-422
    • Joslin, E.P.1    Root, H.F.2    White, P.3
  • 44
    • 0025685412 scopus 로고
    • Subnormal follicular-phase serum progesterone levels and elevated follicular-phase serum estradiol levels in young women with insulin-dependent diabetes
    • Zumoff B, Miller L, Poretsky L, et al. Subnormal follicular-phase serum progesterone levels and elevated follicular-phase serum estradiol levels in young women with insulin-dependent diabetes. Steroids. 1990;55:560-564.
    • (1990) Steroids. , vol.55 , pp. 560-564
    • Zumoff, B.1    Miller, L.2    Poretsky, L.3
  • 46
    • 0025073226 scopus 로고
    • Regulation of human ovarian insulin receptors in vivo
    • Poretsky L, Bhargava G, Saketos M, Dunaif A. Regulation of human ovarian insulin receptors in vivo. Metabolism. 1990;39:161-166.
    • (1990) Metabolism. , vol.39 , pp. 161-166
    • Poretsky, L.1    Bhargava, G.2    Saketos, M.3    Dunaif, A.4
  • 47
    • 0025304396 scopus 로고
    • Second messengers of insulin action
    • Saltiel AR. Second messengers of insulin action. Diabetes Care. 1990;13:244-256.
    • (1990) Diabetes Care. , vol.13 , pp. 244-256
    • Saltiel, A.R.1
  • 48
    • 0031790832 scopus 로고    scopus 로고
    • Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovarian syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system
    • Nestler JE, Jakubowicz DJ, De Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovarian syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83:2001-2005.
    • (1998) J Clin Endocrinol Metab. , vol.83 , pp. 2001-2005
    • Nestler, J.E.1    Jakubowicz, D.J.2    De Vargas, A.F.3    Brik, C.4    Quintero, N.5    Medina, F.6
  • 49
    • 0034917780 scopus 로고    scopus 로고
    • Phosphatidyl-inositol-3 kinase-independent insulin action pathway(s) in the human ovary
    • Poretsky L, Seto-Young D, Shrestha A, et al. Phosphatidyl-inositol-3 kinase-independent insulin action pathway(s) in the human ovary. J Clin Endocrinol Metab. 2001;86:3115-3119.
    • (2001) J Clin Endocrinol Metab. , vol.86 , pp. 3115-3119
    • Poretsky, L.1    Seto-Young, D.2    Shrestha, A.3
  • 51
    • 0027452132 scopus 로고
    • Altered expression of insulin and insulin-like growth factor-I receptors in follicular and stromal compartments of polycystic ovarian ovaries
    • Samoto T, Maruo T, Matsuo H, Katayama K, Barnea ER, Mochizuki M. Altered expression of insulin and insulin-like growth factor-I receptors in follicular and stromal compartments of polycystic ovarian ovaries. Endocr J. 1993;40:413-424.
    • (1993) Endocr J. , vol.40 , pp. 413-424
    • Samoto, T.1    Maruo, T.2    Matsuo, H.3    Katayama, K.4    Barnea, E.R.5    Mochizuki, M.6
  • 52
    • 0030046499 scopus 로고    scopus 로고
    • Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries
    • Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab. 1996;81:302-309.
    • (1996) J Clin Endocrinol Metab. , vol.81 , pp. 302-309
    • Willis, D.1    Mason, H.2    Gilling-Smith, C.3    Franks, S.4
  • 53
    • 27744483698 scopus 로고    scopus 로고
    • Thiazolidinedione action in the human ovary: Insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production
    • Seto-Young D, Paliou M, Schlosser J, et al. Thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. J Clin Endocrinol Metab. 2005;90:6099-6105.
    • (2005) J Clin Endocrinol Metab. , vol.90 , pp. 6099-6105
    • Seto-Young, D.1    Paliou, M.2    Schlosser, J.3
  • 54
    • 34347205695 scopus 로고    scopus 로고
    • Interactions among peroxisome proliferators activated receptor-g, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells
    • Seto-Young D, Avtanski D, Strizhevsky M, et al. Interactions among peroxisome proliferators activated receptor-g, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells. J Clin Endocrinol Metab. 2007;92:2232-2239.
    • (2007) J Clin Endocrinol Metab. , vol.92 , pp. 2232-2239
    • Seto-Young, D.1    Avtanski, D.2    Strizhevsky, M.3
  • 55
    • 33747668788 scopus 로고    scopus 로고
    • Commentary: Polycystic ovary syndrome-increased or preserved ovarian sensitivity to insulin?
    • Poretsky L. Commentary: polycystic ovary syndrome-increased or preserved ovarian sensitivity to insulin? J Clin Endocrinol Metab. 2006;91:2859-2860.
    • (2006) J Clin Endocrinol Metab. , vol.91 , pp. 2859-2860
    • Poretsky, L.1
  • 56
    • 0029796476 scopus 로고    scopus 로고
    • Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
    • Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 1996;335:617-623.
    • (1996) N Engl J Med. , vol.335 , pp. 617-623
    • Nestler, J.E.1    Jakubowicz, D.J.2
  • 57
    • 0030997424 scopus 로고    scopus 로고
    • Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome
    • Sahin Y, Ayata D, Kelestimur F. Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome. Eur J Endocrinol. 1997;136:410-415.
    • (1997) Eur J Endocrinol. , vol.136 , pp. 410-415
    • Sahin, Y.1    Ayata, D.2    Kelestimur, F.3
  • 58
    • 0031022705 scopus 로고    scopus 로고
    • The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovarian syndrome
    • Fulghesu AM, Villa P, Pavone V, et al. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovarian syndrome. J Clin Endocrinol Metab. 1997;82:644-648.
    • (1997) J Clin Endocrinol Metab. , vol.82 , pp. 644-648
    • Fulghesu, A.M.1    Villa, P.2    Pavone, V.3
  • 59
    • 0008274495 scopus 로고
    • Acute augmentation of plasma androstenedione and dehydroepiandrosterone by euglycemic insulin infusion: Evidence for a direct effect of insulin on ovarian steroidogenesis
    • Dunaif A Givens JR Haseltine FP Merriam GR eds Boston: Blackwell Scientific Publications
    • Stuart CA, Nagamani M. Acute augmentation of plasma androstenedione and dehydroepiandrosterone by euglycemic insulin infusion: evidence for a direct effect of insulin on ovarian steroidogenesis. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications; 1992:279-288.
    • (1992) Polycystic Ovary Syndrome , pp. 279-288
    • Stuart, C.A.1    Nagamani, M.2
  • 60
    • 0023269432 scopus 로고
    • Hyperinsulinemia and hyperandrogenemia: In vivo androgen response to insulin infusion
    • Stuart CA, Prince MJ, Peters EJ, Meyer WJ. Hyperinsulinemia and hyperandrogenemia: in vivo androgen response to insulin infusion. Obstet Gynecol. 1987;69:921-925.
    • (1987) Obstet Gynecol. , vol.69 , pp. 921-925
    • Stuart, C.A.1    Prince, M.J.2    Peters, E.J.3    Meyer, W.J.4
  • 61
    • 0028071849 scopus 로고
    • Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome
    • Poretsky L, Piper B. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol. 1994;84:613-621.
    • (1994) Obstet Gynecol. , vol.84 , pp. 613-621
    • Poretsky, L.1    Piper, B.2
  • 62
    • 0019443286 scopus 로고
    • Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells
    • Adashi EY, Hsueh AJW, Yen SSC. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology. 1981;108:1441-1449.
    • (1981) Endocrinology. , vol.108 , pp. 1441-1449
    • Adashi, E.Y.1    Hsueh, A.J.W.2    Yen, S.S.C.3
  • 63
    • 0028127104 scopus 로고
    • Insulin, insulin-like growth factor i (IGF I) and IGF-II enhance basal and gonadotropin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro
    • Soldani R, Cagnacci A, Yen SS. Insulin, insulin-like growth factor I (IGF I) and IGF-II enhance basal and gonadotropin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur J Endocrinol. 1994;131:641-645.
    • (1994) Eur J Endocrinol. , vol.131 , pp. 641-645
    • Soldani, R.1    Cagnacci, A.2    Yen, S.S.3
  • 64
    • 0030783316 scopus 로고    scopus 로고
    • Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens
    • Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab. 1997;82:4075-4079.
    • (1997) J Clin Endocrinol Metab. , vol.82 , pp. 4075-4079
    • Nestler, J.E.1    Jakubowicz, D.J.2
  • 65
    • 0024590991 scopus 로고
    • Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with polycystic ovary syndrome
    • Dunaif A, Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with polycystic ovary syndrome. J Clin Invest. 1989;83:23-29.
    • (1989) J Clin Invest. , vol.83 , pp. 23-29
    • Dunaif, A.1    Graf, M.2
  • 66
    • 0023809454 scopus 로고
    • Inhibition of sex hormone-binding globulin production in the human hepatoma (HepG2) cell line by insulin and prolactin
    • Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (HepG2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67:460-464.
    • (1988) J Clin Endocrinol Metab. , vol.67 , pp. 460-464
    • Plymate, S.R.1    Matej, L.A.2    Jones, R.E.3    Friedl, K.E.4
  • 68
    • 0028062035 scopus 로고
    • Relationship between insulin sensitivity and circulating sex hormonebinding globulin levels in hyperandrogenic obese women
    • Fendri S, Arlot S, Marcelli JM, Dubreuil A, Lalau JD. Relationship between insulin sensitivity and circulating sex hormonebinding globulin levels in hyperandrogenic obese women. Int J Obes Relat Metab Disord. 1994;18:755-759.
    • (1994) Int J Obes Relat Metab Disord. , vol.18 , pp. 755-759
    • Fendri, S.1    Arlot, S.2    Marcelli, J.M.3    Dubreuil, A.4    Lalau, J.D.5
  • 69
    • 0026028184 scopus 로고
    • A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome
    • Nestler JE, Powers LP, Matt DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72:83-89.
    • (1991) J Clin Endocrinol Metab. , vol.72 , pp. 83-89
    • Nestler, J.E.1    Powers, L.P.2    Matt, D.W.3
  • 70
    • 0027770992 scopus 로고
    • Regulation of insulin-like growth factor-I (IGF I) and IGF-binding protein i gene transcription by hormones and provision of amino acids in rat hepatocytes
    • Pao CI, Farmer PK, Begovic S, et al. Regulation of insulin-like growth factor-I (IGF I) and IGF-binding protein I gene transcription by hormones and provision of amino acids in rat hepatocytes. Mol Endocrinol. 1993;7:1561-1568.
    • (1993) Mol Endocrinol. , vol.7 , pp. 1561-1568
    • Pao, C.I.1    Farmer, P.K.2    Begovic, S.3
  • 71
    • 0030778154 scopus 로고    scopus 로고
    • Insulin-like growth factor binding protein-1: Recent findings and
    • new directions
    • Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med. 1997;216:319-357.
    • (1997) Proc Soc Exp Biol Med. , vol.216 , pp. 319-357
    • Lee, P.D.1    Giudice, L.C.2    Conover, C.A.3    Powell, D.R.4
  • 72
    • 0027050848 scopus 로고
    • Insulin-like growth factors and ovarian follicular development
    • Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev. 1992;13:641-669.
    • (1992) Endocr Rev. , vol.13 , pp. 641-669
    • Giudice, L.C.1
  • 73
    • 0025681927 scopus 로고
    • Specific binding sites for insulin-like growth factor i in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis
    • Nagami M, Stuart CA. Specific binding sites for insulin-like growth factor I in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis. Am J Obstet Gynecol. 1990;163:1992-1997.
    • (1990) Am J Obstet Gynecol. , vol.163 , pp. 1992-1997
    • Nagami, M.1    Stuart, C.A.2
  • 74
    • 0030897913 scopus 로고    scopus 로고
    • Effects of insulin and insulin-like growth factors on proliferation of rat ovarian theca-interstitial cells
    • Duleba AJ, Spaczynski RZ, Olive DL, Behrman HR. Effects of insulin and insulin-like growth factors on proliferation of rat ovarian theca-interstitial cells. Biol Reprod. 1997;56:891-897.
    • (1997) Biol Reprod. , vol.56 , pp. 891-897
    • Duleba, A.J.1    Spaczynski, R.Z.2    Olive, D.L.3    Behrman, H.R.4
  • 75
    • 0031906426 scopus 로고    scopus 로고
    • Insulin and insulin-like growth factor i stimulate the proliferation of human ovarian theca-interstitial cells
    • Duleba AJ, Spaczynski RZ, Olive DL. Insulin and insulin-like growth factor I stimulate the proliferation of human ovarian theca-interstitial cells. Fertil Steril. 1998;69:335-340.
    • (1998) Fertil Steril. , vol.69 , pp. 335-340
    • Duleba, A.J.1    Spaczynski, R.Z.2    Olive, D.L.3
  • 76
    • 84892254640 scopus 로고    scopus 로고
    • The effects of ovarian steroids, epidermal growth factor (EGF), insulin (I), and insulin-like growth factor-1 (IGF-I), on ovarian stromal cell growth
    • Minneapolis, MN, (Abstract 389)
    • Watson H, Willis D, Mason H, Modgil G, Wright C, Franks S. The effects of ovarian steroids, epidermal growth factor (EGF), insulin (I), and insulin-like growth factor-1 (IGF-I), on ovarian stromal cell growth. Program of the 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, (Abstract 389), 1997.
    • (1997) Program of the 79th Annual Meeting of the Endocrine Society
    • Watson, H.1    Willis, D.2    Mason, H.3    Modgil, G.4    Wright, C.5    Franks, S.6
  • 77
    • 0032841019 scopus 로고    scopus 로고
    • Insulin has a biphasic effects on the ability of human chorionic gonadotropin to induce ovarian cysts in the rat
    • Bogovich K, Clemons J, Poretsky L. Insulin has a biphasic effects on the ability of human chorionic gonadotropin to induce ovarian cysts in the rat. Metabolism. 1999;48:995-1002.
    • (1999) Metabolism. , vol.48 , pp. 995-1002
    • Bogovich, K.1    Clemons, J.2    Poretsky, L.3
  • 78
    • 0034063157 scopus 로고    scopus 로고
    • Synergistic effects of IGF-I and human chorionic gonadotropin in the rat ovary
    • Damario M, Bogovich K, Liu HC, Rosenwaks Z, Poretsky L. Synergistic effects of IGF-I and human chorionic gonadotropin in the rat ovary. Metabolism. 2000;49:314-320.
    • (2000) Metabolism. , vol.49 , pp. 314-320
    • Damario, M.1    Bogovich, K.2    Liu, H.C.3    Rosenwaks, Z.4    Poretsky, L.5
  • 79
    • 0025744602 scopus 로고
    • Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female
    • De ClueT J, Shah SC, Marchese M, Malone JI. Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female. J Clin Endocrinol Metab. 1991;72:1308-1311.
    • (1991) J Clin Endocrinol Metab. , vol.72 , pp. 1308-1311
    • De Cluet, J.1    Shah, S.C.2    Marchese, M.3    Malone, J.I.4
  • 80
    • 0029880488 scopus 로고    scopus 로고
    • Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome
    • Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81:942-947.
    • (1996) J Clin Endocrinol Metab. , vol.81 , pp. 942-947
    • Dunaif, A.1    Finegood, D.T.2
  • 81
    • 0032948363 scopus 로고    scopus 로고
    • Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
    • Legro R, Kunselman A, Dodson W, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165-169.
    • (1999) J Clin Endocrinol Metab. , vol.84 , pp. 165-169
    • Legro, R.1    Kunselman, A.2    Dodson, W.3    Dunaif, A.4
  • 82
    • 0034977315 scopus 로고    scopus 로고
    • Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes
    • Koivunen RM, et al. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. J Clin Endocrinol Metab. 2001;86:2591-2599.
    • (2001) J Clin Endocrinol Metab. , vol.86 , pp. 2591-2599
    • Koivunen, R.M.1
  • 83
    • 0033760858 scopus 로고    scopus 로고
    • The Diabetes Prevention Program: Baseline characteristics of the randomized cohort
    • The Diabetes Prevention Program Research Group
    • The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care. 2000;23(11):1619-1629.
    • (2000) Diabetes Care. , vol.23 , Issue.11 , pp. 1619-1629
  • 84
    • 0034033860 scopus 로고    scopus 로고
    • Background and recruitment data for the U.S. Diabetes Prevention Program
    • Fujimoto W. Background and recruitment data for the U.S. Diabetes Prevention Program. Diabetes Care. 2000;23:B11-B13.
    • (2000) Diabetes Care , vol.23
    • Fujimoto, W.1
  • 85
    • 0023261237 scopus 로고
    • Spironolactone and estrogen-progestin therapy for hirsuitism
    • Board JA, Rosenberg SM, Smeltzer JS. Spironolactone and estrogen-progestin therapy for hirsuitism. South Med J. 1987;80:483-486.
    • (1987) South Med J. , vol.80 , pp. 483-486
    • Board, J.A.1    Rosenberg, S.M.2    Smeltzer, J.S.3
  • 86
    • 0035187245 scopus 로고    scopus 로고
    • Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome
    • Falsetti L, Gamera A, Tisi G. Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome. Hum Reprod. 2001;16:36-42.
    • (2001) Hum Reprod. , vol.16 , pp. 36-42
    • Falsetti, L.1    Gamera, A.2    Tisi, G.3
  • 87
    • 0021979062 scopus 로고
    • The treatment of hirsuitism with a combination of desogestrel and ethinyl oestradiol
    • Dewis P, Petsos P, Newman M, Anderson DC. The treatment of hirsuitism with a combination of desogestrel and ethinyl oestradiol. Clin Endocrinol. 1985;22:29-36.
    • (1985) Clin Endocrinol. , vol.22 , pp. 29-36
    • Dewis, P.1    Petsos, P.2    Newman, M.3    Anderson, D.C.4
  • 88
    • 0019993445 scopus 로고
    • Effect of body weight reduction on plasma androgens in obese infertile women
    • Bates GW, Whitworth NS. Effect of body weight reduction on plasma androgens in obese infertile women. Fertil Steril. 1982;38:406-409.
    • (1982) Fertil Steril. , vol.38 , pp. 406-409
    • Bates, G.W.1    Whitworth, N.S.2
  • 90
    • 0031835060 scopus 로고    scopus 로고
    • Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment
    • Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998;13:1502-1505.
    • (1998) Hum Reprod. , vol.13 , pp. 1502-1505
    • Clark, A.M.1    Thornley, B.2    Tomlinson, L.3    Galletley, C.4    Norman, R.J.5
  • 91
    • 0029024775 scopus 로고
    • Effects of diet and metformin administration on sex hormone-binding globuliln, androgens, and insulin in hirsute and obese women
    • Crave JC, Fimbel S, Lejeune H, Cugnardey N, DeChaud H, Pugeat M. Effects of diet and metformin administration on sex hormone-binding globuliln, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab. 1995;80: 2057-2062.
    • (1995) J Clin Endocrinol Metab. , vol.80 , pp. 2057-2062
    • Crave, J.C.1    Fimbel, S.2    Lejeune, H.3    Cugnardey, N.4    Dechaud, H.5    Pugeat, M.6
  • 92
    • 0034458234 scopus 로고    scopus 로고
    • Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation
    • Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 2000;85:139-146.
    • (2000) J Clin Endocrinol Metab. , vol.85 , pp. 139-146
    • Moghetti, P.1    Castello, R.2    Negri, C.3
  • 93
    • 0032565971 scopus 로고    scopus 로고
    • Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome
    • Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998;338:1876-1880.
    • (1998) N Engl J Med. , vol.338 , pp. 1876-1880
    • Nestler, J.E.1    Jakubowicz, D.J.2    Evans, W.S.3    Pasquali, R.4
  • 94
    • 0034894566 scopus 로고    scopus 로고
    • The use of insulin-sensitizing agents in patients with polycystic ovary syndrome
    • Bloomgarden ZT, Futterwiet W, Poretsky L. The use of insulin-sensitizing agents in patients with polycystic ovary syndrome. Endocr Pract. 2001;7:279-286.
    • (2001) Endocr Pract. , vol.7 , pp. 279-286
    • Bloomgarden, Z.T.1    Futterwiet, W.2    Poretsky, L.3
  • 95
    • 0030745921 scopus 로고    scopus 로고
    • Menstrual cyclicity after metformin therapy in polycystic ovary syndrome
    • Velazquez E, Acosta A, Mendoza SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol. 1997;90:392-395.
    • (1997) Obstet Gynecol. , vol.90 , pp. 392-395
    • Velazquez, E.1    Acosta, A.2    Mendoza, S.G.3
  • 96
    • 0035044332 scopus 로고    scopus 로고
    • Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome
    • Jakubowicz DJ, Seppala M, Jakubowicz S, et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86:1126-1133.
    • (2001) J Clin Endocrinol Metab. , vol.86 , pp. 1126-1133
    • Jakubowicz, D.J.1    Seppala, M.2    Jakubowicz, S.3
  • 97
    • 33846875851 scopus 로고    scopus 로고
    • Clomiphene metformin or both for infertility in the polycystic ovary syndrome
    • Legro R, Barnhart H, Schlaff W, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356:551-566.
    • (2007) N Engl J Med. , vol.356 , pp. 551-566
    • Legro, R.1    Barnhart, H.2    Schlaff, W.3
  • 98
    • 34548784576 scopus 로고    scopus 로고
    • Clomiphene citrate versus metformin as first-line approach for the treatment of infertile patients with polycystic ovary syndrome
    • Palomba S, Orio F, Falbo A, Russo T, Tolino A, Zullo F. Clomiphene citrate versus metformin as first-line approach for the treatment of infertile patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:3498-3503.
    • (2007) J Clin Endocrinol Metab. , vol.92 , pp. 3498-3503
    • Palomba, S.1    Orio, F.2    Falbo, A.3    Russo, T.4    Tolino, A.5    Zullo, F.6
  • 99
    • 0029795871 scopus 로고    scopus 로고
    • The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
    • Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81:3299-3306.
    • (1996) J Clin Endocrinol Metab. , vol.81 , pp. 3299-3306
    • Dunaif, A.1    Scott, D.2    Finegood, D.3    Quintana, B.4    Whitcomb, R.5
  • 100
    • 0035041906 scopus 로고    scopus 로고
    • Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial
    • Azziz R, Ehrmann D, Legro RS, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab. 2001;86:1626-1632.
    • (2001) J Clin Endocrinol Metab. , vol.86 , pp. 1626-1632
    • Azziz, R.1    Ehrmann, D.2    Legro, R.S.3
  • 101
    • 22344443196 scopus 로고    scopus 로고
    • Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease
    • Dereli D, Dereli T, Bayraktar F, Ozgen A, Yilmaz C. Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease. Endocr J. 2005;52:299-308.
    • (2005) Endocr J. , vol.52 , pp. 299-308
    • Dereli, D.1    Dereli, T.2    Bayraktar, F.3    Ozgen, A.4    Yilmaz, C.5
  • 102
    • 33749035259 scopus 로고    scopus 로고
    • Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: A randomized placebo-controlled study
    • Rautio K, Tapanainen JS, Ruokonen A, Morin-Papunen LC. Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study. Hum Reprod. 2006;21:1400-1407.
    • (2006) Hum Reprod. , vol.21 , pp. 1400-1407
    • Rautio, K.1    Tapanainen, J.S.2    Ruokonen, A.3    Morin-Papunen, L.C.4
  • 103
    • 4043100289 scopus 로고    scopus 로고
    • Effect of insulin sensitizer pioglitazone on insulin resistance, hyper-androgenism, and ovulatory dysfunction in women with polycystic ovary syndrome
    • Brettenthaler N, De Geyter C, Huber P, Keller U. Effect of insulin sensitizer pioglitazone on insulin resistance, hyper-androgenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89: 3835-3840.
    • (2004) J Clin Endocrinol Metab. , vol.89 , pp. 3835-3840
    • Brettenthaler, N.1    De Geyter, C.2    Huber, P.3    Keller, U.4
  • 104
    • 30344460005 scopus 로고    scopus 로고
    • Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome
    • Garmes H, Tambascia M, Zantut-Wittmann D. Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome. Gynecol Endocrinol. 2005;21:317-323.
    • (2005) Gynecol Endocrinol. , vol.21 , pp. 317-323
    • Garmes, H.1    Tambascia, M.2    Zantut-Wittmann, D.3
  • 105
    • 2942677215 scopus 로고    scopus 로고
    • Comparison of the efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: An open-labeled study
    • Ashraf Ganie M, Khurana M, Eunice M, Gulati M, Dwivedi S, Ammini A. Comparison of the efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study. J Clin Endocrinol Metab. 2004;89: 2756-2762.
    • (2004) J Clin Endocrinol Metab. , vol.89 , pp. 2756-2762
    • Ashraf Ganie, M.1    Khurana, M.2    Eunice, M.3    Gulati, M.4    Dwivedi, S.5    Ammini, A.6
  • 106
    • 33144468542 scopus 로고    scopus 로고
    • The effect of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with PCOS
    • Yilmaz M, et al. The effect of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with PCOS. J Endocrinal Invest. 2005;29:1003-1009.
    • (2005) J Endocrinal Invest. , vol.29 , pp. 1003-1009
    • Yilmaz, M.1
  • 107
    • 15944390236 scopus 로고    scopus 로고
    • Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome
    • Ortega-Gonzalez C, Luna S, Hernandez L, et al. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90: 1360-1365.
    • (2005) J Clin Endocrinol Metab. , vol.90 , pp. 1360-1365
    • Ortega-Gonzalez, C.1    Luna, S.2    Hernandez, L.3
  • 108
    • 0036063322 scopus 로고    scopus 로고
    • Clinical, endocrine and metabolic effects of metformin added to ethinyl estradio-cyproterone acetate in non-obese women with polycystic ovary syndrome: A randomized controlled study
    • Elter K, Imir G, Durmusoglu F. Clinical, endocrine and metabolic effects of metformin added to ethinyl estradio-cyproterone acetate in non-obese women with polycystic ovary syndrome: a randomized controlled study. Hum Reprod. 2002;17: 1729-1737.
    • (2002) Hum Reprod. , vol.17 , pp. 1729-1737
    • Elter, K.1    Imir, G.2    Durmusoglu, F.3
  • 109
    • 12444286845 scopus 로고    scopus 로고
    • The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients
    • Cibula D, Fanta M, Vrbikova J, et al. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients. Hum Reprod. 2005;20:180-184.
    • (2005) Hum Reprod. , vol.20 , pp. 180-184
    • Cibula, D.1    Fanta, M.2    Vrbikova, J.3
  • 110
    • 29144439829 scopus 로고    scopus 로고
    • Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance
    • Lemay A, Dodin S, Turcot L, Dechene F, Forest J-C. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance. Hum Reprod. 2006;21: 121-128.
    • (2006) Hum Reprod. , vol.21 , pp. 121-128
    • Lemay, A.1    Dodin, S.2    Turcot, L.3    Dechene, F.4    Forest, J.-C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.